Mild Hyperuricemia: To Treat, or Not to Treat, That is the Question. Suggestions form the URRAH Study

High Blood Press Cardiovasc Prev. 2020 Apr;27(2):119-120. doi: 10.1007/s40292-020-00376-z. Epub 2020 Mar 23.

Author

Andrea Semplicini¹

Affiliation

¹ Department of Medicine (DIMED), University of Padua, via S. Mattia 20, 35121, Padua, Italy. andrea.semplicini@unipd.it.

PMID: 32207069
DOI: 10.1007/s40292-020-00376-z

No abstract available

Publication types

Letter

MeSH terms

Biomarkers / blood
Cardiovascular Diseases / diagnosis
Cardiovascular Diseases / epidemiology
Cardiovascular Diseases / prevention & control*
Clinical Decision-Making
Clinical Trials as Topic
Gout Suppressants / adverse effects
Gout Suppressants / therapeutic use*
Humans
Hyperuricemia / blood
Hyperuricemia / diagnosis
Hyperuricemia / drug therapy*
Hyperuricemia / epidemiology
Risk Assessment
Risk Factors
Severity of Illness Index
Treatment Outcome
Unnecessary Procedures
Uric Acid / blood*

Substances

Biomarkers
Gout Suppressants
Uric Acid